$AVNR Company News 4 stocks to watch 3:47 p.m. Sept.

New Post Public Reply Private Reply Replies (0) Message Board

Sep 21, 2014 at 10:11 AM

$AVNR Company News

4 stocks to watch 3:47 p.m. Sept. 18, 2014 - The Trading Deck
5 companies that will benefit from ALS awareness 7:58 a.m. Aug. 22, 2014 - Jennifer Booton
U.S. stock futures cut rise after retail sales 8:53 a.m. Aug. 13, 2013 - Barbara Kollmeyer
Cree, Flowers Foods in focus Tuesday 8:42 a.m. Aug. 13, 2013 - Wallace Witkowski
Yum Brands shares drop on sour China sales 5:23 p.m. Aug. 12, 2013 - Wallace Witkowski
Avanir to promote Merck's diabetes drug Januvia 4:48 p.m. Aug. 12, 2013 - MarketWatch.com
Avanir shares rise after hours on license deal 6:29 p.m. July 2, 2013 - Wallace Witkowski
Avanir, OptiNose enter N. America licensing deal 5:27 p.m. July 2, 2013 - MarketWatch.com
7 gut checks before the stock market's opening bell 6:43 a.m. April 29, 2013 - Shawn Langlois
Avanir Pharmaceuticals shares down 3% 10:37 a.m. Nov. 17, 2010 - Nick Godt
Monday’s biggest gaining and declining stocks 5:25 p.m. Nov. 1, 2010 - Laura Mandaro
Avanir and Allergan lead drug stocks 1:55 p.m. Nov. 1, 2010 - Val Brickates Kennedy
Avanir leads drug stocks north 10:06 a.m. Nov. 1, 2010 - Val Brickates Kennedy
Rexahn, Avanir gain; Sequenom falls 1:32 p.m. April 7, 2010 - Val Brickates Kennedy
Avanir, Opexa gain ahead of presentations 3:16 p.m. April 6, 2010 - Val Brickates Kennedy
Avanir shares jump 10% in pre-market action 9:27 a.m. April 6, 2010 - Val Brickates Kennedy
Drug stocks pressured by J&J report; Avanir jumps 1:49 p.m. Oct. 13, 2009 - Val Brickates Kennedy
Avanir, Acorda move on MS drug updates 3:51 p.m. Oct. 9, 2009 - Val Brickates Kennedy
Tuesday's biggest gaining and declining stocks 6:10 p.m. Aug. 11, 2009 - MarketWatch
Avanir soars and Javelin sinks on drug studies 1:15 p.m. Aug. 11, 2009 - Val Brickates Kennedy

Weakness Seen in Avanir Pharmaceuticals (AVNR): Stock Falls 6.5% - Tale of the Tape 8:52 a.m. Sept. 19, 2014 - Zacks.com
Merck KGaA Teams Up with Sutro for ADCs Targeting Cancer - Analyst Blog 7:00 p.m. Sept. 18, 2014 - Zacks.com
Insider Trading Alert - RSG, HAL And AVNR Traded By Insiders 10:30 a.m. Sept. 18, 2014 - TheStreet.com
Biotech Stock Roundup: Avanir Soars on Phase II Data, Orexigen's Contrave Approved - Analyst Blog 3:00 p.m. Sept. 17, 2014 - Zacks.com
All Pop And No Sizzle Or Is Avanir Going Higher From Here? 9:30 a.m. Sept. 17, 2014 - Seeking Alpha
Merck KGaA-Lupin Ink Deal, Focus on Emerging Markets - Analyst Blog 4:14 p.m. Sept. 16, 2014 - Zacks.com
Avanir Pharmaceuticals Shoots Up on Positive AVP-923 Data - Analyst Blog 3:50 p.m. Sept. 16, 2014 - Zacks.com
AVANIR Pharmaceuticals (AVNR) Showing Signs Of Perilous Reversal Today 9:45 a.m. Sept. 16, 2014 - TheStreet.com
Is Avanir Pharma Fully Valued After Monday’s Rally? 9:13 a.m. Sept. 16, 2014 - 247WallSt.com
Benzinga's Top #PreMarket Losers 7:11 a.m. Sept. 16, 2014 - benzinga.com
Why Avanir Pharmaceuticals (AVNR) Stock Soared to a One-Year High Today 4:06 p.m. Sept. 15, 2014 - TheStreet.com
Merck KGaA Stops All Tecemotide Studies for Lung Cancer - Analyst Blog 3:42 p.m. Sept. 15, 2014 - Zacks.com
Terex Falls After Lowered Earnings Forecast; Avanir Pharmaceuticals Shares Surge 2:40 p.m. Sept. 15, 2014 - benzinga.com
Concert Pharma rides Avanir's coattails 1:30 p.m. Sept. 15, 2014 - Seeking Alpha
NASDAQ Tumbles 1.1%; Alere Shares Surge Following Proposed $46/Share Offer 12:24 p.m. Sept. 15, 2014 - benzinga.com
Midday Gainers From September 15 - RadioShack Corporation, Rewalk Robotics Ltd And More 11:32 a.m. Sept. 15, 2014 - benzinga.com
Alzheimer’s Study Results Take Avanir Back Up to Multiyear Highs 10:26 a.m. Sept. 15, 2014 - 247WallSt.com
Markets Fall; Cognizant To Acquire TriZetto For $2.7 Billion 10:26 a.m. Sept. 15, 2014 - benzinga.com
Morning Market Movers 8:42 a.m. Sept. 15, 2014 - benzinga.com
Biggest Movers in Healthcare Stocks Now – AVNR PTCT AZN HALO 8:30 a.m. Sept. 15, 2014 - InvestorPlace.com

Positive Study Results, Market Activity, Acquisition Proposal, Earnings Schedules, and Collaboration - Research Reports on Avanir, Jazz, Alere, Intuitive Surgical and GSK 9:05 a.m. Sept. 18, 2014 - PR Newswire - PRF
Critical Alerts For Yahoo!, El Pollo Loco, Avanir Pharmaceuticals, General Electric and Ballard Power Systems Released By InvestorsObserver 9:31 a.m. Sept. 16, 2014 - PR Newswire - PRF
Reveal Insider Trading for Yahoo, Apple, Facebook, Avanir Pharmaceuticals, Tesla Motors, and Twitter 8:55 a.m. Sept. 16, 2014 - PR Newswire - PRF
Avanir Pharmaceuticals Announces Positive Phase II Trial Results for AVP-923 in Treatment of Agitation in Patients with Alzheimer's Disease 8:30 a.m. Sept. 15, 2014 - PR Newswire - PRF
Technical Snapshot on Pharma Stocks - Allergan, Akorn, Mallinckrodt, Mylan, and AVANIR Pharma 9:25 a.m. Sept. 8, 2014 - PR Newswire - PRF
Avanir Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Conference 9:00 a.m. Sept. 2, 2014 - PR Newswire - PRF
Avanir Pharmaceuticals Announces Initiation of Phase II Study of AVP-786 for the Adjunctive Treatment of Major Depressive Disorder 9:00 a.m. Aug. 26, 2014 - PR Newswire - PRF
Technical Analysis on Pharma Equities -- Mylan, AVANIR Pharma, Horizon Pharma, VIVUS, and Auxilium Pharma 9:10 a.m. Aug. 6, 2014 - PR Newswire - PRF
Avanir Pharmaceuticals Reports Fiscal 2014 Third Quarter Financial and Business Update 4:01 p.m. Aug. 5, 2014 - PR Newswire - PRF
Avanir Pharmaceuticals Announces Date of Fiscal 2014 Third Quarter Financial Results and Conference Call 8:31 a.m. July 28, 2014 - GlobeNewswire
Avanir Pharmaceuticals Announces FDA Acceptance of IND for AVP-786 for the Adjunctive Treatment of Major Depressive Disorder 9:15 a.m. July 21, 2014 - PR Newswire - PRF
Mark H.N. Corrigan, M.D., Julie H. McHugh, and William Hunter, M.D. to Serve on EPIRUS Board of Directors 11:50 a.m. July 15, 2014 - BusinessWire - BZX
Executive Appointments and Technical Updates - Analyst Notes on Aeri Pharmaceuticals, DaVita, Prana Biotechnology, Raptor and Avanir Pharmaceuticals 5:10 a.m. July 14, 2014 - PR Newswire - PRF
Stocks Coverage on the Pharma Industry -- Research on Zoetis, Mylan, AVANIR Pharma, and Actavis 6:50 a.m. July 1, 2014 - PR Newswire - PRF
Avanir Pharmaceuticals Announces Two Data Presentations Related to Pseudobulbar Affect (PBA) at the Alzheimer's Association International Conference (AAIC) 7:22 p.m. June 30, 2014 - PR Newswire - PRF
Divestitures, Agreement for Developmental Rights, Data Presentations, Technical Update, and Licensing Agreements - Analyst Notes on Akorn, Merrimack, Avanir, Omeros and TG Therapeutics 6:40 a.m. June 27, 2014 - PR Newswire - PRF
Avanir Pharmaceuticals Announces Positive Outcome of Phase IIIb COMPASS Trial: A Head-to-Head Study Comparing AVP-825 to Oral Sumatriptan for the Acute Treatment of Migraine 4:00 a.m. June 10, 2014 - PR Newswire - PRF
Health Care Sector Equities Scrutiny -- Research on AVANIR Pharma, Zoetis, Actavis, and Mallinckrodt 7:50 a.m. June 3, 2014 - PR Newswire - PRF
Avanir Pharmaceuticals Announces Completion of Patient Enrollment in Study of AVP-923 for the Treatment of Agitation in Patients with Alzheimer's Disease 9:00 a.m. May 27, 2014 - PR Newswire - PRF
Avanir Pharmaceuticals Reports Fiscal 2014 Second Quarter Financial and Business Results 4:01 p.m. May 6, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Perion Acquisition: Affle's Bold Leap in Ad Tech

Affle's Strategic Acquisition of Perion Jumpin' through another hoop, Affle is gearing up to snag Perion in a hefty deal valued at about $420 million. For those of you not knee-deep in the ad tech sandbox, Affle—trading on the NSE as AFFLE—is aiming to ramp up its AI-driven conversion game by absorbing Perion, a veteran in the omnichannel advertising realm. "This...

Ensuring Flooring Stability: Acclimation's Key Role

Dive into the World of Flooring Acclimation You ever hear about flooring acclimation? Sounds as riveting as watching paint dry, right? But Austin J. Messina from Salem, New Hampshire, is here to tell us it's the secret to flooring that doesn't buckle under pressure—literally. Messina's insights, splashed across the pages of HelloNation, delve deep into the nitty-gritty...

Navigating the Maze of Required Minimum Distributions

Understanding Required Minimum Distributions Ever felt like retirement planning is walking a financial tightrope? Well, when it comes to Required Minimum Distributions (RMDs), you're tiptoeing on a wire. These IRS-mandated withdrawals aren't just accounting quirks; they’re a cornerstone of retirement income strategy—a fact unmistakably highlighted by Janie Kelly in...

Nicely Network: Top Reddit Marketing for Big Brands

Reddit and AI: Nicely Network's Winning Formula Straight out of New York comes the latest scoop: Nicely Network's been crowned king of the Reddit jungle, earning the title of Best Reddit Marketing Agency for Enterprise Brands this November, courtesy of Better Business Advice. Now, if you've been paying any attention to how brands are grappling with the impossible search...

Context Labs Unveils AI Distillery for Enterprises

Rethinking AI with Sovereignty in Mind A bouquet of tech buzzwords lands on every investor's doorstep with the unveiling of Context Labs' latest contraption. We’re talking about the AI Distillery™, which promises enterprises a way to run sovereign AI systems by keeping data in-house. Now, if you’re nodding along to the buzz, let's cut through the clutter....

SICO Snags $1.6B in New Investor Mandates for 2026

SICO Makes Waves with Massive New Business Wins Right out of the gate at the Gateway Gulf 2026 Forum, SICO's announcement of a whopping $1.6 billion in new business mandates had even the seasoned pros raising an eyebrow or two. There's nothing like a sweet billion-dollar figure to kickstart the day, huh? This isn't small change we're talking about; this is a tidal wave of...

Tenax Therapeutics Faces Class Action Amid Massive Loss

Investors Eye Deadline Amidst Legal Storm Holy moly, Tenax Therapeutics is caught with their pants down—and we're not talking loose change. Any sorry soul who bought into Tenax's promises about their TNX-103 drug is now staring down a high-stakes class action lawsuit. If you were holding on to those dreams turned nightmares between November 13, 2023, and August 7, 2026,...

Decoding LRV: Smart Paint Choices for Your Home

Unraveling the Secrets of LRV Nobody thought analyzing paint meant diving into light reflectance values (LRV), but that's precisely where we're headed today. Painting a room seems simple until you realize your color choice might turn your bright haven into a cave or vice versa. Thanks to some insights from Wendy Anguiano in HelloNation, let's dig into this technical...

CPC's Rigorous Self-Governance Balances Power Effectively

What's the Deal With Those Ancient Quotes? There's nothing like a quote from the Warring States Period to set the stage for good ol' fashioned governance chatter. Lu Buwei's words about rulers and compass points is historic, sure, but it speaks to the core need for standards in today's China. This isn't just some fortune cookie wisdom; it's a clarion call for order and...

Mastering Progressive Overload: Break Workout Plateaus

Getting off the Fitness Merry-Go-Round You've been hitting the gym, feeling great, and suddenly—bam! You've hit a wall so hard you might as well be a bug on a windshield. That's where our buddy Joshua Bankes comes in, explaining the magic of progressive overload for fitness buffs. Understanding Plateau Phenomena Remember, results aren't linear. As you start a new...